Market perform well despite Omicron

  • Global shares rose 4.0% and 1.7% in hedged and unhedged terms, respectively. Global emerging markets fell 0.6% over the month, based on continuing concerns around the Omicron
  • Australian shares performed reasonably well during December, with the S&P/ASX 200 returning 2.7%. The leading sectors were Utilities (up 88%) and Materials (up 6.43%). I.T. was the worst performing sector (down 5.35%).
  • Fixed income returns ended the month fairly flat, returning 1% domestically and -0.4% globally.
  • The Australian dollar (AUD) rose 1.9% against the US dollar and 3.8% against the Yen. Note given the more hawkish rhetoric from the Fed., the AUD has already given back about 1 cent of December’s

Inflation and Tapering


  • The U.S. consumer price index rose 0.5% for the month of December, 0% on a year-on-year basis, the fastest rate since June 1982. It is now clear that some elements of inflation globally aren’t transitory, while other elements will take significantly longer to dissipate than initially expected.
  • The Fed will be buying $60 billion of bonds each month starting in January, half the level prior to the November taper and $30 billion less than it had been buying in December. The Fed was tapering by $15 billion a month in November, then doubled the taper in December. It will accelerate the tapering further in


  • The International Monetary Fund forecasts that Australia’s GDP will grow 4.1% in 2022 on the back of increased business activity and international borders reopening. However, the Omicron outbreak, which has spread rapidly since mid-December, is likely to make a reasonable dent in economic activity, with some economists and fund managers already reducing Q1 2022 GDP forecasts
  • A key decision coming up for the RBA is whether or not to end QE in February. The next RBA meeting is on the 1st of February. It seems likely, based on the economy outperforming in a few key areas since November, that the RBA will decide to end QE

Major asset class performance


Asset classes 1 month


1 year


5 years (p.a.) %
Australian shares 2.7 17.2 9.8
Australian small companies 1.4 16.9 11.2
Global shares (hedged) 4.0 23.9 14.0
Global shares (unhedged) 1.7 29.6 15.1
Global small companies (unhedged)  






Global emerging markets (unhedged)  






Global listed property (hedged)  






Cash 0.0 0.0 1.1
Australian fixed income 0.1 -2.9 3.4
International fixed income -0.4 -1.5 3.2
Source: Bloomberg & IOOF, 31 December 2021

Indices used: Australian Shares: S&P/ASX 200 Accumulation Index, Australian small companies: S&P/ASX Small Ordinaries Accumulation Index, Global shares (hedged): MSCI World ex Australia Net Total Return (in AUD), Global shares (unhedged): MSCI World ex Australia Hedged AUD Net Total Return Index; Global small companies (unhedged): MSCI World Small Cap Net Total Return USD Index (in AUD); Global emerging markets (unhedged): MSCI Emerging Markets EM Net Total Return AUD Index; Global listed property (hedged): FTSE EPRA/NAREIT Developed Index Hedged in AUD Net Total Return; Cash: Bloomberg AusBond Bank Bill Index; Australian fixed income: Bloomberg AusBond Composite 0+ Yr Index; International fixed income: Bloomberg Barclays Global Aggregate Total Return Index Value Hedged AUD

   Please note: Past performance is not indicative of future performance                     


Currency Markets




Exchange rates

At close on 31/12



1 month change



1 year change


USD/AUD 0.73 1.9 -5.6
Euro/AUD 0.64 1.7 1.5
Yen/AUD 83.7 3.8 5.3
Trade weighted index 61.1 4.5 -3.6
Source: Bloomberg & IOOF, 31 December 2021

All foreign exchange rates are rounded to two decimal places where appropriate.

Please note: Past performance is not indicative of future performance.












This report is prepared by Bridges Financial Services Pty Limited ABN 60 003 474 977 AFSL 240837 (Bridges). Bridges is an ASX Market Participant and part of the IOOF group of companies. This report is prepared by the IOOF Research team for: Bridges Financial Services Pty Limited ABN 60 003 474 977 AFSL 240837, Consultum Financial Advisers Pty Ltd ABN 65 006 373 995 AFSL 230323, Elders Financial Planning ABN 48 007 997 186 AFSL 224645,

Financial Services Partners ABN 15 089 512 587 AFSL 237 590, Millennium3 Financial Services Pty Ltd ABN 61 094 529 987 AFSL 244252, RI Advice Group Pty Ltd ABN 23 001 774 125 AFSL 238429, Shadforth Financial Group Ltd ABN 27 127 508 472 AFSL 318613 (‘Advice Licensees’). The Advice Licensees are part of the IOOF group comprising IOOF Holdings ABN 49 100 103 722 and its related bodies corporate (IOOF group).The Advice Licensees and/or their associated entities, directors and/or employees may have a material interest in, and may earn brokerage from, any securities or other financial products referred to in this document or may provide services to the company referred to in this report. The document is not available for distribution outside Australia and may not be passed on to any third person without the prior written consent of the Advice Licensees. The Advice Licensees and associated persons (including persons from whom information in this report is sourced) may do business or seek to do business with companies covered in its research reports. As a result, investors should be aware that the firms or other such persons may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as a single factor in making an investment decision. The document is current as at the date of issue but may be superseded by future publications. You can confirm the currency of this document by checking the intranet site (links below).The information contained in this report is for the sole use of advisers and clients of AFSL entities authorised by the Advice Licensees. This report may be used on the express condition that you have obtained a copy of the Advice Licensees Financial Services Guide (FSG) from their respective website. Disclaimer: The information in this report is general advice only and does not take into account the financial circumstances, needs and objectives of any particular investor. Before acting on the advice contained in this document, you should assess your own circumstances or seek advice from a financial adviser. Where applicable, you should obtain and consider a copy of the Product Disclosure Statement, prospectus or other disclosure material relevant to the financial product before making a decision to acquire a financial product. It is important to note that investments may go up and down and past performance is not an indicator of future performance. The contents of this report should not be disclosed, in whole or in part, to any other party without the prior consent of the IOOF Research Team and Advice Licensees. To the extent permitted by the law, the IOOF Research team and Advice Licensees and their associated entities are not liable for any loss or damage arising from, or in relation to, the contents of this report. For information regarding any potential conflicts of interest and analyst holdings; IOOF Research Team’s coverage criteria, methodology and spread of ratings; and summary information about the qualifications and experience of the IOOF Research Team please visit

Pin It on Pinterest

Share This